share_log

StockNews.com Begins Coverage on Blonder Tongue Laboratories (NYSE:BDR)

Financial News Live ·  Jul 19, 2022 13:31

StockNews.com started coverage on shares of Blonder Tongue Laboratories (NYSE:BDR – Get Rating) in a research report released on Saturday. The firm issued a hold rating on the stock.

Blonder Tongue Laboratories Price Performance

The company's fifty day moving average is $0.36. Blonder Tongue Laboratories has a twelve month low of $0.28 and a twelve month high of $1.91. The firm has a market capitalization of $4.13 million, a price-to-earnings ratio of -4.43 and a beta of 0.55. The company has a quick ratio of 0.38, a current ratio of 1.11 and a debt-to-equity ratio of 0.64.

Get Blonder Tongue Laboratories alerts:

Blonder Tongue Laboratories (NYSE:BDR – Get Rating) last issued its quarterly earnings data on Friday, May 6th. The company reported ($0.09) EPS for the quarter. Blonder Tongue Laboratories had a negative return on equity of 18.69% and a negative net margin of 4.14%. The company had revenue of $3.34 million for the quarter.

Blonder Tongue Laboratories Company Profile

(Get Rating)

Blonder Tongue Laboratories, Inc, a technology-development and manufacturing company, provides television (TV) signal encoding, transcoding, digital transport, and broadband product solutions in the United States. It offers encoders/transcoders, such as 4K/ultra-high definition, high definition and standard definition, MPEG-2, MPEG-4/H.264, and HEVC/H.265 capable encoders and transcoders; and QPSK and 8PSK, and QAM transcoders.

Featured Stories

  • Get a free copy of the StockNews.com research report on Blonder Tongue Laboratories (BDR)
  • Is it Time to Cash Out Novavax Stock?
  • Should you buy Bank of America Stock After Its Q2 Earnings Report?
  • Monthly Dividend Stocks Can Provide Solid Income
  • AMC Entertainment Is On Track For Blockbuster Results
  • Why Did State Street's Stock Rally Despite Weaker Earnings?

Receive News & Ratings for Blonder Tongue Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blonder Tongue Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment